[应对磺脲类药物（SU）治疗2型糖尿病时副作用的措施] - Suppr

Suppr

超能文献

[Measures to meet the side effects of sulfonylurea (SU) in the treatment of type 2 diabetes].

作者信息

Furukawa Hisashi, Ishida Hitoshi

机构信息

Third Department of Internal Medicine, Kyorin University School of Medicine.

出版信息

Nihon Rinsho. 2002 Sep;60 Suppl 9:357-61.

PMID:12387018

Abstract

摘要

相似文献

[Measures to meet the side effects of sulfonylurea (SU) in the treatment of type 2 diabetes].

Nihon Rinsho. 2002 Sep;60 Suppl 9:357-61.

Worry vs. knowledge about treatment-associated hypoglycaemia and weight gain in type 2 diabetic patients on metformin and/or sulphonylurea.

Curr Med Res Opin. 2012 May;28(5):731-6. doi: 10.1185/03007995.2012.681639. Epub 2012 Apr 24.

Emergency management of oral hypoglycemic drug toxicity.

Emerg Med Clin North Am. 2007 May;25(2):347-56; abstract viii. doi: 10.1016/j.emc.2007.02.010.

Exorcising the specter of nighttime hypoglycemia.

Diabetes Self Manag. 2012 Jan-Feb;29(1):16, 18-20.

Rational choice of oral antihyperglycaemic agents.

J Indian Med Assoc. 2002 Mar;100(3):174-5, 177.

[Pitfalls in treatment with oral antidiabetic agents].

Vnitr Lek. 1998 Jan;44(1):30-5.

Insulin and oral hypoglycemic agents should not be used in combination in the treatment of type 2 diabetes.

Arch Intern Med. 2003;163(15):1783-5; discussion 1785. doi: 10.1001/archinte.163.15.1783.

[Prolonged hypoglycemia after oral anti-diabetic drugs].

Vnitr Lek. 1979 Nov;25(11):1103-5.

Severe sulfonylurea-induced hypoglycemia: a problem of uncritical prescription and deficiencies of diabetes care in geriatric patients.

Expert Opin Drug Saf. 2010 Sep;9(5):675-81. doi: 10.1517/14740338.2010.492777.

The risk of heart failure in patients with type 2 diabetes treated with oral agent monotherapy.

Eur J Heart Fail. 2008 Jul;10(7):703-8. doi: 10.1016/j.ejheart.2008.05.013. Epub 2008 Jun 19.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

[Measures to meet the side effects of sulfonylurea (SU) in the treatment of type 2 diabetes].

Nihon Rinsho. 2002 Sep;60 Suppl 9:357-61.

Worry vs. knowledge about treatment-associated hypoglycaemia and weight gain in type 2 diabetic patients on metformin and/or sulphonylurea.

Curr Med Res Opin. 2012 May;28(5):731-6. doi: 10.1185/03007995.2012.681639. Epub 2012 Apr 24.

Emergency management of oral hypoglycemic drug toxicity.

Emerg Med Clin North Am. 2007 May;25(2):347-56; abstract viii. doi: 10.1016/j.emc.2007.02.010.

Exorcising the specter of nighttime hypoglycemia.

Diabetes Self Manag. 2012 Jan-Feb;29(1):16, 18-20.

Rational choice of oral antihyperglycaemic agents.

J Indian Med Assoc. 2002 Mar;100(3):174-5, 177.

[Pitfalls in treatment with oral antidiabetic agents].

Vnitr Lek. 1998 Jan;44(1):30-5.

Insulin and oral hypoglycemic agents should not be used in combination in the treatment of type 2 diabetes.

Arch Intern Med. 2003;163(15):1783-5; discussion 1785. doi: 10.1001/archinte.163.15.1783.

[Prolonged hypoglycemia after oral anti-diabetic drugs].

Vnitr Lek. 1979 Nov;25(11):1103-5.

Severe sulfonylurea-induced hypoglycemia: a problem of uncritical prescription and deficiencies of diabetes care in geriatric patients.

Expert Opin Drug Saf. 2010 Sep;9(5):675-81. doi: 10.1517/14740338.2010.492777.

The risk of heart failure in patients with type 2 diabetes treated with oral agent monotherapy.

Eur J Heart Fail. 2008 Jul;10(7):703-8. doi: 10.1016/j.ejheart.2008.05.013. Epub 2008 Jun 19.

[Measures to meet the side effects of sulfonylurea (SU) in the treatment of type 2 diabetes].

作者信息

Furukawa Hisashi, Ishida Hitoshi

机构信息

Third Department of Internal Medicine, Kyorin University School of Medicine.

出版信息

Nihon Rinsho. 2002 Sep;60 Suppl 9:357-61.

PMID:12387018

Abstract

摘要